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In this case, the underlying respiratory tract infection 
most likely enhanced the antiarrhythmic effect of nortrip-
tyline by causing faster heart rates (up to 130 beats/min in 
the emergency department), thereby enabling the sodium 
channel blocking potential of nortriptyline, enhanced by 
flecainide, which ultimately resulted in third-degree heart 
block.
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Answer
At presentation, the 12-lead electrocardiogram (ECG) 
showed third-degree AV block with an escape rhythm origi-
nating from the anterior fascicle of the left bundle branch 
(Fig. 1). The subsequent electrocardiograms showed sec-
ond-degree heart block type Wenckebach, only confined 
to the left bundle branch (Figs. 2, 3). Within one day, all 
the conduction disturbances disappeared and the ECG was 
identical to previous ECGs at regular control visits.
Flecainide is a class 1C antiarrhythmic drug that blocks 
the sodium channel and is known for its ability to prolong 
the right atrial, atrioventricular, and His-Purkinje conduction 
time, although it does not slow AV conduction [1]. Nortrip-
tyline has a ‘quinidine-like’ antiarrhythmic effect and can 
cause conduction disturbances, amongst which third-degree 
AV block [2]. Its class 1A and 1C antiarrhythmic effects 
may block the cardiac sodium channel and can, especially 
in combination with other causes of cardiac sodium channel 
blockage (such as flecainide), lead to a relevant reduction of 
intracellular sodium.
Moreover, the antiarrhythmic effects of both flecainide 
and nortriptyline are use-dependent, i.e. requiring repeti-
tive opening and closing of the sodium channels to act as 
a sodium channel blocker, thus more effective at fast heart 
rates [3].
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